AstraZeneca Pharmaceuticals LP v. Blue Cross Blue Shield of Massachusetts
177 L. Ed. 2d 1150, 131 S. Ct. 60, 561 U.S. 1056, 2010 U.S. LEXIS 5762
CourtSupreme Court of the United States
DecidedSeptember 28, 2010
DocketNo. 09-1069 (R46-032)
StatusPublished
Cited by3 cases
This text of 177 L. Ed. 2d 1150 (AstraZeneca Pharmaceuticals LP v. Blue Cross Blue Shield of Massachusetts) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
AstraZeneca Pharmaceuticals LP v. Blue Cross Blue Shield of Massachusetts, 177 L. Ed. 2d 1150, 131 S. Ct. 60, 561 U.S. 1056, 2010 U.S. LEXIS 5762 (U.S. 2010).
Opinion
The petition for writ of certiorari to the United States Court of Appeals for the First Circuit in the above-entitled case was dismissed today pursuant to Rule 46 of the Rules of this Court.
Same case below, 582 F.3d 156.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Federated Ins. Co. v. Summit Pharmacy (WC Fee Rev. Hearing Office)
Commonwealth Court of Pennsylvania, 2024
Commonwealth v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.
52 A.3d 498 (Commonwealth Court of Pennsylvania, 2012)
Com. v. TAP PHARMACEUTICAL PRODUCTS, INC.
36 A.3d 1112 (Commonwealth Court of Pennsylvania, 2011)
Cite This Page — Counsel Stack
Bluebook (online)
177 L. Ed. 2d 1150, 131 S. Ct. 60, 561 U.S. 1056, 2010 U.S. LEXIS 5762, Counsel Stack Legal Research, https://law.counselstack.com/opinion/astrazeneca-pharmaceuticals-lp-v-blue-cross-blue-shield-of-massachusetts-scotus-2010.